Heart Failure Diagnostic And Monitoring Device Market: By Product, By Tests, Echocardiogram, Stress Test, Cardiac Computerized Tomography Scan or Magnetic Resonance Imaging, Coronary Angiogram, and Myocardial Biopsy) and Geography

Heart Failure Diagnostic And Monitoring Device Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (ECG Systems, Holter Monitors, Event Monitors, and Implantable Loop Recorders), By Tests (Blood Tests, Chest X-Ray, Electrocardiogram (ECG), Echocardiogram, Stress Test, Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI), Coronary Angiogram, and Myocardial Biopsy) and Region

Heart Failure Diagnostic And Monitoring Device Market size was valued at US$ 3,936.8 million in 2023 and is poised to grow at a significant CAGR of 4.8% over 2024–2030. Heart failure, also known as congestive heart failure, is a condition that develops when the heart muscle is unable to pump blood effectively or when it results in other states, including high blood pressure, high cholesterol, blood vessel narrowing, and others. The diagnosis of heart failure can be made in several ways, including blood tests, chest x-rays, echocardiograms, and others. The incidence of heart failure is rising, as are other conditions like diabetes, atherosclerosis, stroke, hypertension, and others.

The market is also growing due to sedentary lifestyle habits, technological advancements in cardiac heart failure treatment devices, and the number of older adults. However, several obstacles limit the market's growth, including reimbursement concerns and the high cost of diagnosing appliances in emerging economies. Shortly, new emerging technology in cardiovascular treatment & diagnostics will create many chances in undiscovered areas. The future market expansion for ambulatory cardiac monitoring devices is being aided by the increasing demand for cutting-edge cardiac equipment, including Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. The market for ambulatory cardiac monitoring devices is also driven by favorable reimbursement policies, increasing government and individual healthcare spending, and other essential factors.

Key businesses implement different tactics to broaden product offerings and global geographic presence. Companies use various techniques to increase their market presence, including product portfolio growth, mergers and acquisitions, technological breakthroughs, and increased research and development. For instance, in August 2021, Advanced Medical Predictive Devices, (AMP3D), Diagnostics and Displays Inc.'s extensive library of clinical predictive algorithms and one-of-a-kind software-as-a-service (SaaS) platform were acquired by Nihon Kohden. In order to depict real-time and continuous risk trajectories, AMP3D's CoMET software makes use of patient continuous monitoring data, vital signs, medical records, and laboratory test data.

Heart Failure Diagnostic And Monitoring Device Market Key Developments:

  • In January 2021, Boston Scientific acquired Preventice Solutions, a remote cardiac monitoring product developer; it has been a partner and an investor for the later since 2015.
  • In February 2021, Remo Care Solutions introduced a new AI-based remote monitoring device for cardiac patients that analyzes the cardiovascular conditions of the patients in real time.
  • In December 2020, Philips acquired BioTelemetry, Inc. This will integrate the patient monitoring services of Philips with cardiac diagnostics and monitoring services of the BioTelemetry in hospitals.

Heart Failure Diagnostic And Monitoring Device Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

4.8%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Heart Failure Diagnostic And Monitoring Device Market Dynamics

Growing adherence to destructive lifestyles, such as rising nicotine and cigarette use, unhealthy food consumption, and increasing body mass index, contribute to the rise in heart failure cases and the growth of heart failure testing. The most frequent causes of the market expansion for heart failure monitoring devices are rising rates of disorders like diabetes and hypertension. Another reason anticipated to fuel the expansion of the heart failure diagnostic and monitoring device market is the rising prevalence of coronary artery disorders. The main factors influencing the market's growth are the increasing obesity rate and the aging population. On the other hand, due to the hazards connected with this technology, the FDA has regulatory oversight over the market for heart failure monitoring and diagnostic devices.

Heart Failure Diagnostic And Monitoring Device Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024 - 2030

Market Size in 2023

US$ 3,936.8 million

Market CAGR

4.8%

By Product Type

  • ECG Systems
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders

By Test Type

  • Blood Tests
  • Chest X-Ray
  • Electrocardiogram (ECG)
  • Echocardiogram
  • Stress Test
  • Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
  • Coronary Angiogram
  • Myocardial Biopsy

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The heart failure diagnostic and monitoring device market is projected to expand at a CAGR of 4.8% during the forecast period

Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE and Co. KG, Boston Scientific Corporation

North America is the fastest-growing region for heart failure diagnostic and monitoring device market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Heart Failure Diagnostic And Monitoring Device Market Introduction 
2.1.Global Heart Failure Diagnostic And Monitoring Device Market  - Taxonomy
2.2.Global Heart Failure Diagnostic And Monitoring Device Market  - Definitions
2.2.1.By Product Type
2.2.2.By Test Type
2.2.3.By Geography
2.2.4.Region
3.Global Heart Failure Diagnostic And Monitoring Device Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Heart Failure Diagnostic And Monitoring Device Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Heart Failure Diagnostic And Monitoring Device Market  By By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. ECG Systems
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Holter Monitors
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Event Monitors
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Implantable Loop Recorders
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Heart Failure Diagnostic And Monitoring Device Market  By By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Blood Tests
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Chest X-Ray
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Electrocardiogram (ECG)
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Echocardiogram
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Stress Test
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Coronary Angiogram
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Myocardial Biopsy
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Heart Failure Diagnostic And Monitoring Device Market  By By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. The Asia Pacific
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Latin America
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. MEA
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Heart Failure Diagnostic And Monitoring Device Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.ECG Systems
9.1.2.Holter Monitors
9.1.3.Event Monitors
9.1.4.Implantable Loop Recorders
9.2.  By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Blood Tests
9.2.2.Chest X-Ray
9.2.3.Electrocardiogram (ECG)
9.2.4.Echocardiogram
9.2.5.Stress Test
9.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
9.2.7.Coronary Angiogram
9.2.8.Myocardial Biopsy
9.3.  By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.North America
9.3.2.Europe
9.3.3.The Asia Pacific
9.3.4.Latin America
9.3.5.MEA
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.ECG Systems
10.1.2.Holter Monitors
10.1.3.Event Monitors
10.1.4.Implantable Loop Recorders
10.2.  By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Blood Tests
10.2.2.Chest X-Ray
10.2.3.Electrocardiogram (ECG)
10.2.4.Echocardiogram
10.2.5.Stress Test
10.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
10.2.7.Coronary Angiogram
10.2.8.Myocardial Biopsy
10.3.  By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.North America
10.3.2.Europe
10.3.3.The Asia Pacific
10.3.4.Latin America
10.3.5.MEA
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.ECG Systems
11.1.2.Holter Monitors
11.1.3.Event Monitors
11.1.4.Implantable Loop Recorders
11.2.  By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Blood Tests
11.2.2.Chest X-Ray
11.2.3.Electrocardiogram (ECG)
11.2.4.Echocardiogram
11.2.5.Stress Test
11.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
11.2.7.Coronary Angiogram
11.2.8.Myocardial Biopsy
11.3.  By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.North America
11.3.2.Europe
11.3.3.The Asia Pacific
11.3.4.Latin America
11.3.5.MEA
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.ECG Systems
12.1.2.Holter Monitors
12.1.3.Event Monitors
12.1.4.Implantable Loop Recorders
12.2.  By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Blood Tests
12.2.2.Chest X-Ray
12.2.3.Electrocardiogram (ECG)
12.2.4.Echocardiogram
12.2.5.Stress Test
12.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
12.2.7.Coronary Angiogram
12.2.8.Myocardial Biopsy
12.3.  By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.North America
12.3.2.Europe
12.3.3.The Asia Pacific
12.3.4.Latin America
12.3.5.MEA
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.ECG Systems
13.1.2.Holter Monitors
13.1.3.Event Monitors
13.1.4.Implantable Loop Recorders
13.2.  By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Blood Tests
13.2.2.Chest X-Ray
13.2.3.Electrocardiogram (ECG)
13.2.4.Echocardiogram
13.2.5.Stress Test
13.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI)
13.2.7.Coronary Angiogram
13.2.8.Myocardial Biopsy
13.3.  By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.North America
13.3.2.Europe
13.3.3.The Asia Pacific
13.3.4.Latin America
13.3.5.MEA
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.Beckman Coulter
14.2.3.Abiomed Inc.
14.2.4.Berlin Heart GmbH
14.2.5.Biotronik SE and Co. KG
14.2.6.Boston Scientific Corporation
14.2.7.HeartWare International Inc.
14.2.8.Jarvik Heart Inc.
14.2.9.Medtronic plc
14.2.10.Jude Medical
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • Beckman Coulter
  • Abiomed Inc.
  • Berlin Heart GmbH
  • Biotronik SE and Co. KG
  • Boston Scientific Corporation
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic plc
  • Jude Medical

Related Industry Reports